| [1] |
Krag D N, Anderson S J, Julian T B, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically nodenegative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol,2007,8:881 -888.
|
| [2] |
Goyal A, Newcombe R G, Chhabra A, et al. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase. Breast Cancer Res Treat,2006,99:203 -208.
|
| [3] |
Mansel R E, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst,2006,98:599 -609.
|
| [4] |
Leitch A M, McCall L, Beitsch P, et al. Factors influencing accrual to ACOSOG Z0011, a randomized phase III trial of axillary dissection vs. observation for sentinel node positive breast cancer. J Clin Oncol,2006,24:601.
|
| [5] |
Mansel R E, Goyal A. European studies on breast lymphatic mapping. Semin Oncol,2004,31:304 -310.
|
| [6] |
Ung OA. Australasian experience and trials in sentinel lymph node biopsy: the RACSSNAC trial. Asian J Surg, 2004,27:284 -290.
|
| [7] |
Lyman G H, Giuliano A E, Somergield M R, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol,2005,23:7703 -7720.
|
| [8] |
NCCN. Breast cancer practice guidelines. Practice Guidelines in Oncology(V.2.2008). The National Comprehensive Cancer Network,2008.
|
| [9] |
Schrenk P,Wayand W. Sentinel-node biopsy in axillary lymphnode staging for patients with multicentric breast cancer.Lancet,2001,357:122.
|
| [10] |
Tousimis E, Van Zee K J, Fey J V, et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancer. J Am Coll Surg,2003,197:529 -535.
|
| [11] |
Knauer M,Konstantiniuk P,Haid A, et al. Multicentric breast cancer: a new indication for sentinel node biopsy - a multiinstitutional validation study. J Clin Oncol, 2006,24:3374 -3380.
|
| [12] |
Intra M, Rotmensz N, Veronesi P, et al. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg,2008,247:315 -319.
|
| [13] |
Yen T W, Hunt K K, Ross M I, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg,2005,200:516 -526.
|
| [14] |
Dominguez F J, Golshan M, Black D M, et al. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.Ann Surg Oncol,2008,15:268 -273.
|
| [15] |
Cox C E, Dupont E, Whitehead G F, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J,2002,8:88 -91.
|
| [16] |
Luini A, Galimberti V, Gatti G, et al. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat,2005,89:159 -163.
|
| [17] |
王水,刘晓安,赵佳,等. 染料法乳腺癌前哨淋巴通道的研究.中华外科杂志,2006,44:748 -750.
|
| [18] |
Xing Y, Foy M, Cox D D, et al. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg,2006,93:539 -546.
|
| [19] |
Lee S, Kim E Y,Kang S H,et al. Sentinel node identification rate, but not accuracy, is significantly decreased after preoperative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat,2007,102:283 -288.
|
| [20] |
Kinoshita T. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy. Breast Cancer,2007,14:10 -15.
|
| [21] |
Sanidas E E, Daskalakis M, Sbyrakis N, et al. Modifications of the learning curve guidelines for breast cancer sentinel node biopsy. Eur J Surg Oncol,2005,31:357 -363.
|
| [22] |
Clarke D, Newcombe R G, Mansel R E. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol,2004,11:S211 -S215.
|
| [23] |
American Joint Committe on Cancer. Cancer Staging Atlas.New York:Springer,2006.
|
| [24] |
Choi Y J,Yun H R,Yoo K E,et al. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer. Jpn J Clin Oncol,2006,36:489-493.
|
| [25] |
Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res,2007,13:4807 -4816.
|
| [26] |
Teng S, Dupont E, McCann C, et al. Do cytokeratin-positiveonly sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am Surg,2000,66:574 -578.
|
| [27] |
Cox C E,Kiluk J V,Riker A I, et al. Significance of sentinel lymph node micrometastases in human hreast cancer.J Am Coll Surg,2008,206:261 -268.
|